What are the signs and symptoms of severe mitral regurgitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Signs and Symptoms of Severe Mitral Regurgitation

Severe mitral regurgitation presents differently depending on whether it develops acutely or chronically, with acute cases manifesting as cardiogenic shock and pulmonary edema, while chronic cases present with progressive dyspnea, fatigue, and exercise intolerance.

Acute Severe Mitral Regurgitation

When severe MR develops suddenly, the left atrium and ventricle have not had time to adapt to the large regurgitant volume, resulting in dramatic hemodynamic consequences 1:

Clinical Manifestations

  • Hypotension (present in 72% of cases) 2
  • Hypoxia (64% of cases) 2
  • Pulmonary edema (12% of cases) 2
  • Orthopnea (14% of cases) 2
  • Cardiogenic shock 1

Physical Examination Findings

The mitral systolic murmur in acute severe MR may be softer or even absent compared to chronic MR due to rapid equalization of left atrial and ventricular pressures 3. This is a critical pitfall—the absence of a loud murmur does not exclude severe acute MR.

Chronic Severe Mitral Regurgitation

In chronic MR, the left atrium gradually dilates to accommodate increased volume, allowing patients to remain compensated for extended periods 4.

Symptoms (Stage D Disease)

According to the 2014 AHA/ACC guidelines 5, symptomatic severe MR presents with:

  • Heart failure symptoms that persist despite optimal medical therapy
  • Decreased exercise tolerance
  • Exertional dyspnea
  • Fatigue (from reduced forward cardiac output) 4

The 2017 ESC/EACTS guidelines 6 emphasize that symptoms in secondary MR should be assessed after optimization of medical therapy including cardiac resynchronization therapy (CRT) if indicated, as symptoms may initially respond to these interventions.

Physical Examination Findings

  • Holosystolic murmur at the apex, typically radiating to the axilla
  • The murmur intensity remains unchanged after premature beats or long pauses in atrial fibrillation (distinguishing it from aortic stenosis) 4
  • Increases with isometric handgrip exercise 4
  • Decreases during Valsalva strain phase 4
  • Hyperdynamic precordium (from volume overload)
  • Displaced apical impulse (from left ventricular dilation)

Associated Cardiac Findings

For Primary MR (Stage C-D) 5:

  • New onset atrial fibrillation
  • Pulmonary hypertension (pulmonary artery systolic pressure >50 mm Hg)
  • Left atrial enlargement
  • Left ventricular dilation with preserved systolic function initially
  • Later: Left ventricular dysfunction (LVEF ≤60%, LVESD ≥40 mm)

For Secondary MR (Stage C-D) 5:

  • Regional wall motion abnormalities with reduced LV systolic function
  • LV dilation and systolic dysfunction from primary myocardial disease
  • Severe tethering of mitral leaflets
  • Annular dilation with loss of central coaptation

Critical Timing Considerations

A major pitfall is waiting for symptoms to develop before intervening. Recent evidence suggests a survival penalty when waiting for traditional class I surgical indications 7. The insidious development of chronic MR can lead to irreversible left ventricular dysfunction before symptoms become apparent 4.

Early Warning Signs (Asymptomatic Stage C)

Even before symptoms develop, severe MR may manifest with:

  • New-onset atrial fibrillation 5
  • Resting pulmonary hypertension (PA systolic pressure >50 mm Hg) 5
  • Progressive left ventricular enlargement (LVESD approaching 40 mm) 5
  • Declining ejection fraction (approaching 60%) 5

Distinguishing Acute from Chronic

Echocardiographic differentiation 3, 8:

  • Acute MR: Normal-sized left atrium, segmental LV dysfunction, flail leaflet, no time for chamber remodeling
  • Chronic MR: Dilated left atrium, atrial fibrillation common, compensatory LV dilation, preserved EF until late stages

Hemodynamic Severity Criteria

Severe MR is defined by 5:

  • Effective regurgitant orifice (ERO) ≥0.40 cm² (primary MR) or ≥0.20 cm² (secondary MR)
  • Regurgitant volume ≥60 mL (primary MR) or ≥30 mL (secondary MR)
  • Regurgitant fraction ≥50%

Note: Secondary MR uses lower thresholds because these values are associated with worse prognosis 6, though it remains unclear if prognosis is independently affected by MR versus underlying LV dysfunction.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.